The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells

Biomaterials

Volumn 30, Issue 6, 2009, Pages 1232-1245

  Gaymalov, Zagit Z ^a   Yang, Zhihui ^a   Pisarev, Vladimir M ^b   Alakhov, Valery Yu ^c   Kabanov, Alexander V ^a,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Supratek Pharma Inc   (Canada)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Copolymer; Gene expression; Leukocyte; Pluronics

Indexed keywords

ANIMAL CELL CULTURE; ANTIGENS; BIOACTIVITY; BLOCK COPOLYMERS; BODY FLUIDS; CELL CULTURE; CELL PROLIFERATION; COPOLYMERIZATION; CYTOLOGY; DENDRIMERS; DNA; ETHYLENE; GENE EXPRESSION; GENES; MACROPHAGES; MUSCLE; NUCLEIC ACIDS; ORGANIC ACIDS; PROPYLENE; VACCINES;

BACTERIAL PLASMIDS; CELL POPULATIONS; DENDRITIC CELLS; DNA VACCINES; ETHYLENE OXIDES; IMMUNE SYSTEMS; KERATINOCYTES; LEUKOCYTE; LOCAL EXPANSIONS; LYMPH NODES; MOUSE MODELS; MYOCYTES; NATURAL KILLERS; NONIONIC BLOCK COPOLYMERS; PLURONIC; PLURONICS; PROPYLENE OXIDES; SKELETAL MUSCLES; TRANSGENE; TRANSGENE EXPRESSIONS; TRIBLOCK CO POLYMERS;

POLYMERS;

PLASMID DNA; PLURONIC P85; POLOXAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HISTOPATHOLOGY; KERATINOCYTE; LYMPH NODE; MACROPHAGE; MOUSE; MUSCLE CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; ANTIGEN-PRESENTING CELLS; BIOLOGICAL MARKERS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAMUSCULAR; LUCIFERASES; MICE; MICE, INBRED BALB C; MUSCLES; NF-KAPPA B; ORGAN SPECIFICITY; PLASMIDS; POLOXAMER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 57849126671     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.10.064     Document Type: Article

References (48)

1. Brichard V.G., and Lejeune D. GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. Vaccine 25 Suppl. 2 (2007) B61-B71
2. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6 2 (2000) 207-210
3. Terando A.M., Faries M.B., and Morton D.L. Vaccine therapy for melanoma: current status and future directions. Vaccine (2007)
4. Markel H. The search for effective HIV vaccines. N Engl J Med 353 8 (2005) 753-757
5. Sharpe S., Hanke T., Tinsley-Bown A., Dennis M., Dowall S., McMichael A., et al. Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. Virology 313 1 (2003) 13-21
6. Forde G.M. Rapid-response vaccines - does DNA offer a solution?. Nat Biotechnol 23 9 (2005) 1059-1062
7. Ulmer J.B., DeWitt C.M., Chastain M., Friedman A., Donnelly J.J., McClements W.L., et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18 1-2 (1999) 18-28
8. Barouch D.H., Santra S., Steenbeke T.D., Zheng X.X., Perry H.C., Davies M.E., et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol 161 4 (1998) 1875-1882
9. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A 90 23 (1993) 11307-11311
10. Hunter R., Strickland F., and Kezdy F. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance. J Immunol 127 3 (1981) 1244-1250
11. Hunter R.L. Overview of vaccine adjuvants: present and future. Vaccine 20 Suppl. 3 (2002) S7-S12
12. Kabanov A., Zhu J., and Alakhov V. Pluronic block copolymers for gene delivery. Adv Genet 53PA (2005) 231-261
13. Pitard B., Pollard H., Agbulut O., Lambert O., Vilquin J.T., Cherel Y., et al. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther 13 14 (2002) 1767-1775
14. Sriadibhatla S., Yang Z., Gebhart C., Alakhov V.Y., and Kabanov A. Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells. Mol Ther 13 4 (2006) 804-813
15. Astafieva I., Maksimova I., Lukanidin E., Alakhov V., and Kabanov A. Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer. FEBS Lett 389 3 (1996) 278-280
16. Lemieux P., Guerin N., Paradis G., Proulx R., Chistyakova L., Kabanov A., et al. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 7 11 (2000) 986-991
17. Yang Z., Zhu J., Sriadibhatla S., Gebhart C., Alakhov V., and Kabanov A. Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J Control Release 108 2-3 (2005) 496-512
18. Robinson S.N., Chavez J.M., Pisarev V.M., Mosley R.L., Rosenthal G.J., Blonder J.M., et al. Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice. Bone Marrow Transplant 31 5 (2003) 361-369
19. Sang H., Pisarev V.M., Munger C., Robinson S., Chavez J., Hatcher L., et al. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity. Vaccine 21 21-22 (2003) 3019-3029
20. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 27 12 (2006) 573-579
21. Kabanov A.V., and Alakhov V.Y. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 19 1 (2002) 1-72
22. Alakhov V., Klinski E., Li S., Pietrzynski G., Venne A., Batrakova E., et al. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf B Biointerfaces 16 1 (1999) 113-134
23. Danson S., Ferry D., Alakhov V., Margison J., Kerr D., Jowle D., et al. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 90 11 (2004) 2085-2091
24. Batrakova E.V., Li S., Alakhov V.Y., Elmquist W.F., Miller D.W., and Kabanov A.V. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res 20 10 (2003) 1581-1590
25. Riera M., Chillon M., Aran J.M., Cruzado J.M., Torras J., Grinyo J.M., et al. Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissues. J Gene Med 6 1 (2004) 111-118
26. Hartikka J., Sukhu L., Buchner C., Hazard D., Bozoukova V., Margalith M., et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 4 5 (2001) 407-415
27. Hunter R.L., McNicholl J., and Lal A.A. Mechanisms of action of nonionic block copolymer adjuvants. AIDS Res Hum Retroviruses 10 Suppl. 2 (1994) S95-S98
28. Allison A.C., and Byars N.E. Adjuvant formulations and their mode of action. Semin Immunol 2 5 (1990) 369-374
29. Ratanamart J., Huggins C.G., Kirby J.A., and Shaw J.A. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids. J Gene Med 9 8 (2007) 703-714
30. Davis H.L., Millan C.L., and Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 4 3 (1997) 181-188
31. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., van Drunen L., and van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
32. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 5388 (1998) 476-480
33. Wilson N.S., El-Sukkari D., Belz G.T., Smith C.M., Steptoe R.J., Heath W.R., et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102 6 (2003) 2187-2194
34. Singh M., and O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 17 11 (1999) 1075-1081
35. Atkinson T.P., Smith T.F., and Hunter R.L. In vitro release of histamine from murine mast cells by block co-polymers composed of polyoxyethylene and polyoxypropylene. J Immunol 141 4 (1988) 1302-1306
36. Johnston T.P., and Miller S.C. Toxicological evaluation of poloxamer vehicles for intramuscular use. J Parenter Sci Technol 39 2 (1985) 83-89
37. Armstrong A., Brewer J., Newman C., Alakhov V., Pietrzynski G., Campbell S., et al. SP1049C as first-line therapy in advanced (inoperable or metastatic) adenocarcinoma of the oesophagus: a phase II window study. J Clin Oncol 2006 24 (2006) 4080
38. Ratanamart J., and Shaw J.A. Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?. Curr Gene Ther 6 1 (2006) 93-110
39. Sasaki S., Takeshita F., Xin K.Q., Ishii N., and Okuda K. Adjuvant formulations and delivery systems for DNA vaccines. Methods 31 3 (2003) 243-254
40. Yang Z., Sahay G., Sriadibhatla S., and Kabanov A.V. Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem 19 10 (2008) 1987-1994
41. Nicchitta C.V. Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat Rev Immunol 3 5 (2003) 427-432
42. Batrakova E.V., Li S., Alakhov V.Y., Miller D.W., and Kabanov A.V. Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther 304 2 (2003) 845-854
43. Sahay G., Batrakova E.V., and Kabanov A.V. Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjug Chem 19 10 (2008) 2023-2029
44. Anderson R.G. The caveolae membrane system. Annu Rev Biochem 67 (1998) 199-225
45. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25 10 (2007) 1159-1164
46. Moghimi S.M., Hunter A.C., Dadswell C.M., Savay S., Alving C.R., and Szebeni J. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. Biochim Biophys Acta 1689 2 (2004) 103-113
47. Klink D., Yu Q.C., Glick M.C., and Scanlin T. Lactosylated poly-l-lysine targets a potential lactose receptor in cystic fibrosis and non-cystic fibrosis airway epithelial cells. Mol Ther 7 1 (2003) 73-80
48. Kozlov M.Y., Melik-Hubarov N.S., Batrakova E., and Kabanov A. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules 33 9 (2000) 3305-3313